• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向miR-103a-3p/IGFBP5轴:一种针对胃癌进展的潜在治疗策略。

Targeting miR-103a-3p/IGFBP5 axis: a potential therapeutic strategy for gastric cancer progression.

作者信息

Zhang Junrui, Qiu Yue, Ma Fubin, Niu Xingdong, Bai Pengwei, Da Mingxu, Ma Junfeng

机构信息

The First School of Clinical Medicine, Gansu University of Chinese Medicine, Lanzhou, 730000, China.

Department of Internal Medicine, Shenzhen People's Hospital, Shenzhen, 518000, China.

出版信息

Discov Oncol. 2025 Apr 22;16(1):591. doi: 10.1007/s12672-025-02390-w.

DOI:10.1007/s12672-025-02390-w
PMID:40263134
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12014892/
Abstract

Gastric cancer is a significant contributor to worldwide cancer deaths with limited treatment options and poor patient survival. MicroRNAs play crucial roles as potential oncogenic factors or tumor suppressors in cancers by modulating cell cycle progression, proliferation, migration, invasion, and apoptosis. However, the functional implications of miR-103a-3p in gastric cancer remain poorly known. The current study demonstrates a noteworthy increase in the expression of miR-103a-3p in gastric cancer tissues when compared to neighboring non-cancerous tissues. Our functional investigations indicate that the upregulation of miR-103a-3p contributes to enhanced proliferation, invasion, and migration capabilities in gastric cancer cells. After mechanistic studies, our findings indicate that miR-103a-3p may directly target insulin-like growth factor binding protein 5 (IGFBP5) in gastric cancer. Moreover, rescue experiments reveal that IGFBP5 overexpression can attenuate the progression induced by miR-103a-3p in gastric cancer cells. In summary, our findings suggest that the miR-103a-3p/IGFBP5 axis may play a role in gastric cancer progression, highlighting its potential as a therapeutic target and prognostic marker.

摘要

胃癌是全球癌症死亡的一个重要原因,治疗选择有限,患者生存率低。微小RNA通过调节细胞周期进程、增殖、迁移、侵袭和凋亡,作为潜在的致癌因素或肿瘤抑制因子在癌症中发挥关键作用。然而,miR-103a-3p在胃癌中的功能意义仍鲜为人知。目前的研究表明,与邻近的非癌组织相比,miR-103a-3p在胃癌组织中的表达显著增加。我们的功能研究表明,miR-103a-3p的上调有助于增强胃癌细胞的增殖、侵袭和迁移能力。经过机制研究,我们的发现表明,miR-103a-3p可能在胃癌中直接靶向胰岛素样生长因子结合蛋白5(IGFBP5)。此外,挽救实验表明,IGFBP5过表达可以减弱miR-103a-3p诱导的胃癌细胞进展。总之,我们的发现表明,miR-103a-3p/IGFBP5轴可能在胃癌进展中起作用,突出了其作为治疗靶点和预后标志物的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4961/12014892/d394d29a4657/12672_2025_2390_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4961/12014892/b19719da1e9e/12672_2025_2390_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4961/12014892/51edbf062647/12672_2025_2390_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4961/12014892/9ebb85b3b5c4/12672_2025_2390_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4961/12014892/7bb959b77efe/12672_2025_2390_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4961/12014892/d394d29a4657/12672_2025_2390_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4961/12014892/b19719da1e9e/12672_2025_2390_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4961/12014892/51edbf062647/12672_2025_2390_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4961/12014892/9ebb85b3b5c4/12672_2025_2390_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4961/12014892/7bb959b77efe/12672_2025_2390_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4961/12014892/d394d29a4657/12672_2025_2390_Fig5_HTML.jpg

相似文献

1
Targeting miR-103a-3p/IGFBP5 axis: a potential therapeutic strategy for gastric cancer progression.靶向miR-103a-3p/IGFBP5轴:一种针对胃癌进展的潜在治疗策略。
Discov Oncol. 2025 Apr 22;16(1):591. doi: 10.1007/s12672-025-02390-w.
2
Down-regulation of EVA1A by miR-103a-3p promotes hepatocellular carcinoma cells proliferation and migration.miR-103a-3p 下调 EVA1A 促进肝癌细胞的增殖和迁移。
Cell Mol Biol Lett. 2022 Oct 22;27(1):93. doi: 10.1186/s11658-022-00388-8.
3
miR-103a-3p Suppresses Cell Proliferation and Invasion by Targeting Tumor Protein D52 in Prostate Cancer.miR-103a-3p 通过靶向肿瘤蛋白 D52 抑制前列腺癌细胞增殖和侵袭。
J Invest Surg. 2021 Sep;34(9):984-992. doi: 10.1080/08941939.2020.1738602. Epub 2020 Mar 13.
4
Knockdown of microRNA-103a-3p inhibits the malignancy of thyroid cancer cells through Hippo signaling pathway by upregulating LATS1.敲低 microRNA-103a-3p 通过上调 LATS1 抑制 Hippo 信号通路抑制甲状腺癌细胞的恶性行为。
Neoplasma. 2020 Nov;67(6):1266-1278. doi: 10.4149/neo_2020_191224N1331. Epub 2020 Aug 4.
5
miRNA-103a-3p Promotes Human Gastric Cancer Cell Proliferation by Targeting and Suppressing ATF7 .miRNA-103a-3p 通过靶向和抑制 ATF7 促进人胃癌细胞增殖。
Mol Cells. 2018 May 31;41(5):390-400. doi: 10.14348/molcells.2018.2078. Epub 2018 May 10.
6
Inhibition of miR-103a-3p suppresses the proliferation in oral squamous cell carcinoma cells via targeting RCAN1.miR-103a-3p 的抑制通过靶向 RCAN1 抑制口腔鳞状细胞癌细胞的增殖。
Neoplasma. 2020 May;67(3):461-472. doi: 10.4149/neo_2020_190430N382. Epub 2020 Feb 28.
7
miR-103a-2-5p/miR-30c-1-3p inhibits the progression of prostate cancer resistance to androgen ablation therapy via targeting androgen receptor variant 7.miR-103a-2-5p/miR-30c-1-3p 通过靶向雄激素受体变体 7 抑制前列腺癌对雄激素剥夺治疗的耐药进展。
J Cell Biochem. 2019 Aug;120(8):14055-14064. doi: 10.1002/jcb.28680. Epub 2019 Apr 8.
8
MicroRNA-103a-3p Promotes Cell Proliferation and Invasion in Non-Small-Cell Lung Cancer Cells through Akt Pathway by Targeting PTEN.微小 RNA-103a-3p 通过靶向 PTEN 促进非小细胞肺癌细胞中的 Akt 通路促进细胞增殖和侵袭。
Biomed Res Int. 2021 Jul 7;2021:7590976. doi: 10.1155/2021/7590976. eCollection 2021.
9
MiR-103a-3p promotes tumour glycolysis in colorectal cancer via hippo/YAP1/HIF1A axis.微小RNA-103a-3p通过河马/Yes相关蛋白1/缺氧诱导因子1α轴促进结直肠癌的肿瘤糖酵解。
J Exp Clin Cancer Res. 2020 Nov 20;39(1):250. doi: 10.1186/s13046-020-01705-9.
10
Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway.Linc00152 通过调控 miR-103a-3p/FEZF1/CDC25A 通路促进神经胶质瘤干细胞的恶性进展。
Mol Cancer. 2017 Jun 26;16(1):110. doi: 10.1186/s12943-017-0677-9.

本文引用的文献

1
inhibits gastric cancer progression the serpin family E member 1- extracellular signal-regulated kinase-1/2 axis.丝氨酸蛋白酶抑制剂家族E成员1-细胞外信号调节激酶-1/2轴抑制胃癌进展。
World J Gastrointest Oncol. 2024 May 15;16(5):2123-2140. doi: 10.4251/wjgo.v16.i5.2123.
2
Regulatory effects of miR-19a on MAD2 expression and tumorigenesis in gastric cancer.miR-19a对胃癌中MAD2表达及肿瘤发生的调控作用
Genes Dis. 2023 Mar 27;10(4):1180-1182. doi: 10.1016/j.gendis.2023.02.025. eCollection 2023 Jul.
3
MiRNA-Based Therapies for Lung Cancer: Opportunities and Challenges?
基于 miRNA 的肺癌治疗:机遇与挑战?
Biomolecules. 2023 May 23;13(6):877. doi: 10.3390/biom13060877.
4
Pan-cancer analysis of oncogenic role of insulin-like growth factor-binding proteins and validation in ovarian cancer.泛癌症分析胰岛素样生长因子结合蛋白的致癌作用及其在卵巢癌中的验证。
Cancer Med. 2023 Jul;12(13):14833-14850. doi: 10.1002/cam4.6073. Epub 2023 May 18.
5
Down-regulation of EVA1A by miR-103a-3p promotes hepatocellular carcinoma cells proliferation and migration.miR-103a-3p 下调 EVA1A 促进肝癌细胞的增殖和迁移。
Cell Mol Biol Lett. 2022 Oct 22;27(1):93. doi: 10.1186/s11658-022-00388-8.
6
MiR-103a-3p Contributes to the Progression of Colorectal Cancer by Regulating GREM2 Expression.miR-103a-3p 通过调控 GREM2 的表达促进结直肠癌的进展。
Yonsei Med J. 2022 Jun;63(6):520-529. doi: 10.3349/ymj.2022.63.6.520.
7
A Comprehensive and Comparative Review of Global Gastric Cancer Treatment Guidelines.全球胃癌治疗指南的全面比较性综述
J Gastric Cancer. 2022 Mar;22(1):3-23. doi: 10.5230/jgc.2022.22.e10. Epub 2022 Mar 31.
8
Emerging concepts of miRNA therapeutics: from cells to clinic.miRNA 治疗学的新观念:从细胞到临床。
Trends Genet. 2022 Jun;38(6):613-626. doi: 10.1016/j.tig.2022.02.006. Epub 2022 Mar 15.
9
The promotional effect of microRNA-103a-3p in cervical cancer cells by regulating the ubiquitin ligase FBXW7 function.microRNA-103a-3p 通过调控泛素连接酶 FBXW7 功能促进宫颈癌的发生。
Hum Cell. 2022 Mar;35(2):472-485. doi: 10.1007/s13577-021-00649-2. Epub 2022 Jan 30.
10
MiR-103a-3p aggravates renal cell carcinoma by targeting TMEM33.微小RNA-103a-3p通过靶向跨膜蛋白33加重肾细胞癌。
Am J Transl Res. 2021 Nov 15;13(11):12694-12703. eCollection 2021.